SCA Pharmaceuticals, a Little Rock, Arkansas-headquartered company specializing in sterile compounding, has opened a 90,000-square-foot manufacturing facility in Windsor, Connecticut. SCA is an FDA 503B outsourcing facility providing sterile admixtures and prefilled syringes to hospitals and surgery centers.

The new facility features cGMP cleanrooms and GLP quality control laboratories.

The company employs more than 360 employees with more than 140 in Connecticut. As the Windsor facility expands over the next three years, SCA plans to add over 200 additional full-time positions.

Source: SCA Pharmaceuticals